NIP
IMGN

Nicholas Investment Partners’s Immunogen Inc IMGN Stock Holding History

Nicholas Investment Partners’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-148,672
Closed -$4.41M – 231
2023
Q4 		$4.41M Sell
148,672
-1,918,889
-93% -$38.2M 0.52% 73
2023
Q3 		$32.8M Buy
2,067,561
+843,434
+69% +$14M 2.45% 7
2023
Q2 		$23.1M Buy
+1,224,127
New +$14.5M 1.58% 19

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Nicholas Investment Partners's IMGN Position: Q1 2024 in Review

Nicholas Investment Partners sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 148,672 shares — an estimated $4.41M sold.

Nicholas Investment Partners first reported a position in IMGN in Q2 2023 and held it in 3 quarters. The position peaked at $32.8M in Q3 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Nicholas Investment Partners reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Nicholas Investment Partners sold 148,672 Immunogen Inc shares in Q1 2024, an estimated $4.41M.
  • Nicholas Investment Partners first reported a position in Immunogen Inc in Q2 2023 and held it in 3 quarters.
  • Nicholas Investment Partners's Immunogen Inc position peaked at $32.8M in Q3 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Nicholas Investment Partners's 13F filing for Q1 2024, filed 14 May 2024.